Profile
Breakthrough T1D, located at 1757 Central Ave Suite 102 in Albany, New York, serves as a prominent foundation dedicated to advancing research in type 1 diabetes (T1D). The organization focuses on funding innovative research aimed at curing, preventing, and treating T1D and its associated complications. This foundation plays a vital role in the global effort to combat T1D, emphasizing collaboration with various stakeholders, including researchers, industry leaders, and healthcare professionals. Breakthrough T1D operates on a mission to enhance the quality of life for individuals affected by T1D. By strategically aligning with diverse sectors, the foundation aims to accelerate the development of life-changing therapies. This commitment ensures that advancements in T1D research transition smoothly from the laboratory to practical applications, ultimately benefiting those living with the condition. The organization’s focus on a coordinated global approach highlights its leadership in the field of diabetes research. Recognition within the scientific community underscores the foundation’s dedication to addressing the challenges posed by T1D. Breakthrough T1D continues to foster a culture of innovation and collaboration, driving significant progress in diabetes research. Engaging with the foundation provides opportunities for individuals and organizations to contribute to this critical mission, promoting a healthier future for those impacted by type 1 diabetes.
Map
Sorry, no records were found. Please adjust your search criteria and try again.
Sorry, unable to load the Maps API.